Takeda to Offload Non-Core Assets in Latin America to Adium

September 21, 2021
Takeda Pharmaceutical said on September 17 that it will divest a batch of non-core products sold in Latin America to Uruguayan drug maker Adium Pharma for an undisclosed sum - the latest in a series of divestiture deals aimed at...read more